Do analysts rate RCEL or QTI?

Avita Medical presently has a consensus target price of $7.25, indicating a potential upside of 63.29%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avita Medical 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is RCEL or QTI more profitable?

QT Imaging has a net margin of -58.93% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% QT Imaging -58.93% -4,220.38% -51.77%

Does the media prefer RCEL or QTI?

In the previous week, Avita Medical had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for Avita Medical and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat Avita Medical's score of 0.39 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral QT Imaging 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate STEX or QTI?

Biosig Technologies presently has a consensus target price of $8.00, suggesting a potential upside of 1,061.95%. Given Biosig Technologies' higher probable upside, equities analysts plainly believe Biosig Technologies is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer STEX or QTI?

In the previous week, QT Imaging had 1 more articles in the media than Biosig Technologies. MarketBeat recorded 4 mentions for QT Imaging and 3 mentions for Biosig Technologies. QT Imaging's average media sentiment score of 1.78 beat Biosig Technologies' score of 0.63 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QT Imaging 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend QTI or CVRX?

CVRx has a consensus price target of $11.50, suggesting a potential upside of 132.09%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has higher valuation & earnings, QTI or CVRX?

QT Imaging has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QT Imaging $18.92M 1.97 -$21.08M -$1.24 N/A CVRx $56.65M 2.32 -$53.31M -$2.02 N/A

Is QTI or CVRX more profitable?

QT Imaging has a net margin of -58.93% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -58.93% -4,220.38% -51.77% CVRx -89.14% -120.76% -48.38%

Does the media refer more to QTI or CVRX?

In the previous week, CVRx had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for CVRx and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat CVRx's score of 1.41 indicating that QT Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QT Imaging 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive CVRx 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate STIM or QTI?

Neuronetics presently has a consensus target price of $4.00, suggesting a potential upside of 119.78%. Given Neuronetics' stronger consensus rating and higher possible upside, equities analysts clearly believe Neuronetics is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is STIM or QTI more profitable?

Neuronetics has a net margin of -24.48% compared to QT Imaging's net margin of -58.93%. Neuronetics' return on equity of -139.83% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -24.48% -139.83% -27.13% QT Imaging -58.93% -4,220.38% -51.77%

Does the media prefer STIM or QTI?

In the previous week, Neuronetics had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for Neuronetics and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat Neuronetics' score of 0.98 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QT Imaging 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer GUTS or QTI?

Fractyl Health presently has a consensus target price of $5.12, suggesting a potential upside of 642.03%. Given Fractyl Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Fractyl Health is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, GUTS or QTI?

QT Imaging has higher revenue and earnings than Fractyl Health. QT Imaging is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,216.32 -$140.95M -$1.29 N/A QT Imaging $18.92M 1.97 -$21.08M -$1.24 N/A

Is GUTS or QTI more profitable?

Fractyl Health has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Fractyl Health's return on equity of -4,053.15% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% QT Imaging -58.93% -4,220.38% -51.77%

Does the media prefer GUTS or QTI?

In the previous week, QT Imaging had 2 more articles in the media than Fractyl Health. MarketBeat recorded 4 mentions for QT Imaging and 2 mentions for Fractyl Health. QT Imaging's average media sentiment score of 1.78 beat Fractyl Health's score of 1.17 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QT Imaging 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

QT Imaging (QTI) Competitors

$2.71 +0.06 (+2.26%)

Closing price 07/29/2026 03:59 PM Eastern

Extended Trading

$2.92 +0.21 (+7.75%)

As of 07/29/2026 07:38 PM Eastern

Compare

QTI vs. RCEL, STEX, CVRX, STIM, and GUTS

Should you buy QT Imaging stock or one of its competitors? MarketBeat compares QT Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QT Imaging include Avita Medical (RCEL), Biosig Technologies (STEX), CVRx (CVRX), Neuronetics (STIM), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry.

How does QT Imaging compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

QT Imaging has a net margin of -58.93% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Avita Medical has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market.

Avita Medical presently has a consensus target price of $7.25, indicating a potential upside of 63.29%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

QT Imaging has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.91	-$48.59M	-$1.57	N/A
QT Imaging	$18.92M	1.97	-$21.08M	-$1.24	N/A

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for Avita Medical and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat Avita Medical's score of 0.39 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
QT Imaging	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Avita Medical and QT Imaging tied by winning 8 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and QT Imaging (NASDAQ:QTI) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Biosig Technologies has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Biosig Technologies' return on equity of -717.92% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Biosig Technologies has a beta of 1.94, suggesting that its stock price is 94% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, suggesting that its stock price is 104% less volatile than the broader market.

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by company insiders. Comparatively, 25.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Biosig Technologies presently has a consensus target price of $8.00, suggesting a potential upside of 1,061.95%. Given Biosig Technologies' higher probable upside, equities analysts plainly believe Biosig Technologies is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

QT Imaging has higher revenue and earnings than Biosig Technologies. QT Imaging is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	3,129.23	-$462.77M	-$9.71	N/A
QT Imaging	$18.92M	1.97	-$21.08M	-$1.24	N/A

In the previous week, QT Imaging had 1 more articles in the media than Biosig Technologies. MarketBeat recorded 4 mentions for QT Imaging and 3 mentions for Biosig Technologies. QT Imaging's average media sentiment score of 1.78 beat Biosig Technologies' score of 0.63 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biosig Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QT Imaging	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Biosig Technologies and QT Imaging tied by winning 7 of the 14 factors compared between the two stocks.

How does QT Imaging compare to CVRx?

QT Imaging (NASDAQ:QTI) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

CVRx has a consensus price target of $11.50, suggesting a potential upside of 132.09%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 25.4% of QT Imaging shares are held by company insiders. Comparatively, 13.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

QT Imaging has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

In the previous week, CVRx had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for CVRx and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat CVRx's score of 1.41 indicating that QT Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QT Imaging	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
CVRx	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

QT Imaging has a net margin of -58.93% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
CVRx	-89.14%	-120.76%	-48.38%

QT Imaging has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	1.97	-$21.08M	-$1.24	N/A
CVRx	$56.65M	2.32	-$53.31M	-$2.02	N/A

Summary

CVRx beats QT Imaging on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 8.4% of Neuronetics shares are held by company insiders. Comparatively, 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Neuronetics had 2 more articles in the media than QT Imaging. MarketBeat recorded 6 mentions for Neuronetics and 4 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.78 beat Neuronetics' score of 0.98 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QT Imaging	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Neuronetics has a net margin of -24.48% compared to QT Imaging's net margin of -58.93%. Neuronetics' return on equity of -139.83% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-24.48%	-139.83%	-27.13%
QT Imaging	-58.93%	-4,220.38%	-51.77%

QT Imaging has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	0.85	-$39M	-$0.54	N/A
QT Imaging	$18.92M	1.97	-$21.08M	-$1.24	N/A

Neuronetics presently has a consensus target price of $4.00, suggesting a potential upside of 119.78%. Given Neuronetics' stronger consensus rating and higher possible upside, equities analysts clearly believe Neuronetics is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Neuronetics has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, meaning that its stock price is 104% less volatile than the broader market.

Summary

Neuronetics beats QT Imaging on 11 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

In the previous week, QT Imaging had 2 more articles in the media than Fractyl Health. MarketBeat recorded 4 mentions for QT Imaging and 2 mentions for Fractyl Health. QT Imaging's average media sentiment score of 1.78 beat Fractyl Health's score of 1.17 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fractyl Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QT Imaging	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Fractyl Health presently has a consensus target price of $5.12, suggesting a potential upside of 642.03%. Given Fractyl Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Fractyl Health is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Fractyl Health has a beta of 2.29, indicating that its stock price is 129% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market.

24.2% of QT Imaging shares are owned by institutional investors. 8.5% of Fractyl Health shares are owned by company insiders. Comparatively, 25.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

QT Imaging has higher revenue and earnings than Fractyl Health. QT Imaging is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,216.32	-$140.95M	-$1.29	N/A
QT Imaging	$18.92M	1.97	-$21.08M	-$1.24	N/A

Fractyl Health has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Fractyl Health's return on equity of -4,053.15% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Summary

Fractyl Health and QT Imaging tied by winning 8 of the 16 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTI vs. The Competition

Export

Metric	QT Imaging	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$36.49M	$70.84M	$7.08B	$12.15B
Dividend Yield	N/A	N/A	2.65%	8.53%
P/E Ratio	-2.19	8.94	27.40	23.33
Price / Sales	1.97	191.79	521.07	86.08
Price / Cash	N/A	41.36	51.57	59.34
Price / Book	5.02	4.40	10.06	5.74
Net Income	-$21.08M	-$5.50M	$3.60B	$336.32M
7 Day Performance	-3.21%	-2.97%	-1.40%	-1.96%
1 Month Performance	-33.42%	-13.96%	-4.38%	-6.16%
1 Year Performance	48.90%	70.70%	20.26%	13.66%

QT Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTI QT Imaging	0.9424 of 5 stars	$2.71 +2.3%	N/A	+46.5%	$36.49M	$18.92M	N/A	N/A	News Coverage Upcoming Earnings
RCEL Avita Medical	3.3186 of 5 stars	$4.61 -6.7%	$7.25 +57.3%	-22.8%	$152.04M	$71.61M	N/A	130	Upcoming Earnings
STEX Biosig Technologies	3.1906 of 5 stars	$0.76 +0.3%	$8.00 +947.1%	N/A	$138.45M	$40K	N/A	50
CVRX CVRx	2.3551 of 5 stars	$4.89 -3.9%	$11.50 +135.2%	-40.0%	$135.07M	$56.65M	N/A	160	News Coverage Positive News Upcoming Earnings
STIM Neuronetics	3.5981 of 5 stars	$1.88 -2.6%	$4.00 +112.8%	-59.3%	$134.30M	$149.16M	N/A	180

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTI) was last updated on 7/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Competitors

QTI vs. RCEL, STEX, CVRX, STIM, and GUTS

How does QT Imaging compare to Avita Medical?

Summary

How does QT Imaging compare to Biosig Technologies?

Summary

How does QT Imaging compare to CVRx?

Summary

How does QT Imaging compare to Neuronetics?

Summary

How does QT Imaging compare to Fractyl Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Competitors

QTI vs. RCEL, STEX, CVRX, STIM, and GUTS

How does QT Imaging compare to Avita Medical?

Is RCEL or QTI more profitable?

Which has more volatility and risk, RCEL or QTI?

Do analysts rate RCEL or QTI?

Which has preferable earnings & valuation, RCEL or QTI?

Do insiders and institutionals believe in RCEL or QTI?

Does the media prefer RCEL or QTI?

Summary

How does QT Imaging compare to Biosig Technologies?

Is STEX or QTI more profitable?

Which has more volatility & risk, STEX or QTI?

Do insiders & institutionals hold more shares of STEX or QTI?

Do analysts rate STEX or QTI?

Which has stronger earnings & valuation, STEX or QTI?

Does the media prefer STEX or QTI?

Summary

How does QT Imaging compare to CVRx?

Do analysts recommend QTI or CVRX?

Do insiders & institutionals hold more shares of QTI or CVRX?

Which has more risk & volatility, QTI or CVRX?

Does the media refer more to QTI or CVRX?

Is QTI or CVRX more profitable?

Which has higher valuation & earnings, QTI or CVRX?

Summary

How does QT Imaging compare to Neuronetics?

Do institutionals & insiders have more ownership in STIM or QTI?

Does the media prefer STIM or QTI?

Is STIM or QTI more profitable?

Which has stronger valuation and earnings, STIM or QTI?

Do analysts rate STIM or QTI?

Which has more risk & volatility, STIM or QTI?

Summary

How does QT Imaging compare to Fractyl Health?

Does the media prefer GUTS or QTI?

Do analysts prefer GUTS or QTI?

Which has more volatility & risk, GUTS or QTI?

Do insiders and institutionals have more ownership in GUTS or QTI?

Which has better valuation and earnings, GUTS or QTI?

Is GUTS or QTI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools